Related Experiment Video
Updated: May 14, 2026

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
Anatomical connection strength predicts dopaminergic drug effects on fronto-striatal function
Martine R van Schouwenburg1, Marcel P Zwiers, Marieke E van der Schaaf
1Centre for Cognitive Neuroimaging, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, and Department of Psychiatry, Radboud University Nijmegen Medical Centre, 6500 HB Nijmegen, The Netherlands. m.vanschouwenburg@donders.ru.nl
Individual differences in white matter tracts predict how dopamine drugs affect fronto-striatal brain function, particularly attention switching. This suggests personalized therapies based on brain anatomy.
Area of Science:
- Neuroscience
- Psychopharmacology
- Neuroimaging
Background:
- Dopamine is crucial for cognitive functions and fronto-striatal circuitry.
- Individual responses to dopaminergic drugs vary significantly.
Purpose of the Study:
- To explore the link between individual differences in white matter tracts and dopaminergic drug effects on fronto-striatal function.
- To investigate if anatomical connectivity predicts drug responses.
Main Methods:
- Functional magnetic resonance imaging (fMRI) assessed bromocriptine effects in 22 healthy volunteers.
- A placebo-controlled, double-blind, within-subject design was used.
- Combined psychopharmacology, neuroimaging, functional, and structural connectivity analyses.
Main Results:
- Bromocriptine modulated functional signals in the basal ganglia related to attention switching.
- Individual differences in fronto-striato-thalamic white matter tracts predicted these drug effects.
- Anatomical fronto-striatal connectivity predicted drug effects on functional connectivity between basal ganglia and prefrontal cortex.
Conclusions:
- Reinforces the connection between dopamine, cognition, and basal ganglia function.
- Highlights the potential for tailoring dopaminergic drug therapy based on individual fronto-striatal anatomy.
- Suggests anatomical connection strength is a key factor in drug response variability.
More Related Videos
11:26Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake
Published on: September 21, 2017
05:14Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Related Concept Videos
Neurochemical Transmission: Sites of Drug Action
Drugs Affecting Neurotransmitter Synthesis
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...